Janus kinase 1 selective inhibitor and pharmaceutical use thereof
US10407430B2 · kind B2 · utility
0Cited by
3References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 19, 2016 |
| Grant date | Sep 10, 2019 |
| Priority date | — |
| Expiry date | Aug 19, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are Janus kinase 1 selective inhibitors of Formula 1 or Formula 2: wherein R1, R2, and X are as described herein. Pharmaceutical uses thereof, for example, for the treatment of a disease associated with a Janus kinase, are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.